All Articles

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

Amid market moderation, TerraCap's latest Florida acquisition highlights the enduring value of infill industrial assets and strategic capital improvements.

Truist's appointment of Lindsey Stampone isn't just a new hire; it's a calculated move to challenge rivals in the competitive PA & NJ banking markets.

After years of stabilization, a 90% stake in real estate firm DEMIRE is for sale. The move by Apollo and Wecken & Cie. could reshape the firm and signal a market shift.

A new R&D pact between ARCYN Defense and the U.S. Army isn't just a press release; it's a strategic maneuver in the multi-billion dollar C-UAS market.

Metropolitan Dermatology is the first in NJ to adopt Nevisense®, an AI-backed scanner for melanoma. Is this tech a true game-changer or one move in a complex market?

As rural hospitals face financial collapse, a new wave of AI-powered technology is proving it can stabilize finances and preserve access to essential care.

TelyRx just filled its millionth prescription, but the real story isn't the number. It's the 'operational innovation' of its cash-pay model that's disrupting healthcare.

Promising early data for obesity drug DA-1726 shows rapid weight loss, while vanoglipel demonstrates powerful synergy in MASH and diabetes combination therapies.

BestFarewell's appointment of Rianka Dorsainvil isn't just a hire; it's a signal. A look at how AI and human expertise are converging in a new system for legacy.

TOYO's landmark investment in a Houston HJT solar cell facility signals a new era for America's energy independence and high-efficiency manufacturing.

Patagonia Gold celebrates first gold from its Calcatreu mine, a major operational win that ignites Argentina's Rio Negro economy amid deep-seated local dissent.

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.

As the world's biggest sporting event expands across North America, a new digital guide aims to be a crucial safety net. Is this the new playbook for mega-events?

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

With its new CryoTherm Palm, Therabody bets on thermoregulation to boost athletic power. We analyze the science, the strategy, and what it means for the future of wellness tech.

Hub International appoints Faizal Mitha as VP of AI Sales Innovation, a move to embed AI in sales and drive growth, setting a new bar for the industry.

Medtronic veteran Jesse Litwak joins ProVerum, a move signaling the BPH innovator is shifting from R&D to aggressive commercial scale-up with its new ProVee tech.